Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).

Article Details

Citation

Copy to clipboard

Magesh S, Moriya S, Suzuki T, Miyagi T, Ishida H, Kiso M

Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).

Bioorg Med Chem Lett. 2008 Jan 15;18(2):532-7. Epub 2007 Nov 28.

PubMed ID

18068975 [ View in PubMed

]

Abstract

We here report the design and synthesis of selective human lysosomal sialidase (NEU1) inhibitors. A series of amide-linked C9 modified DANA (2-deoxy-2,3-dehydro-N-acetylneuraminic acid) analogues were synthesized and their inhibitory activities against all four human sialidases (NEU1-NEU4) were determined. Structure-based approach was used to investigate the basis of selectivity of the compounds with experimentally observed activity. Results from the present study are found to be informative in a qualitative manner for the further design of isoform selective human sialidase inhibitors for therapeutic value.

DrugBank Data that Cites this Article

Binding Properties

Drug	Target	Property	Measurement	pH	Temperature (°C)
2-deoxy-2,3-dehydro-N-acetylneuraminic acid	Sialidase-2	IC 50 (nM)	43000	N/A	N/A	Details